Annual FCF
$414.50 M
-$24.90 M-5.67%
31 December 2023
Summary:
West Pharmaceutical Services annual free cash flow is currently $414.50 million, with the most recent change of -$24.90 million (-5.67%) on 31 December 2023. During the last 3 years, it has risen by +$116.40 million (+39.05%). WST annual FCF is now -5.67% below its all-time high of $439.40 million, reached on 31 December 2022.WST Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$98.80 M
+$34.00 M+52.47%
30 September 2024
Summary:
West Pharmaceutical Services quarterly free cash flow is currently $98.80 million, with the most recent change of +$34.00 million (+52.47%) on 30 September 2024. Over the past year, it has dropped by -$35.50 million (-26.43%). WST quarterly FCF is now -27.30% below its all-time high of $135.90 million, reached on 31 December 2022.WST Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$321.60 M
-$35.50 M-9.94%
30 September 2024
Summary:
West Pharmaceutical Services TTM free cash flow is currently $321.60 million, with the most recent change of -$35.50 million (-9.94%) on 30 September 2024. Over the past year, it has dropped by -$98.40 million (-23.43%). WST TTM FCF is now -26.81% below its all-time high of $439.40 million, reached on 31 December 2022.WST TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
WST Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.7% | -26.4% | -23.4% |
| 3 y3 years | +39.0% | -20.8% | -5.7% |
| 5 y5 years | +125.4% | +29.3% | +49.4% |
WST Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -5.7% | +39.0% | -27.3% | +258.0% | -26.8% | at low |
| 5 y | 5 years | -5.7% | +125.4% | -27.3% | +295.2% | -26.8% | +49.4% |
| alltime | all time | -5.7% | +4864.4% | -27.3% | +330.8% | -26.8% | +1980.7% |
West Pharmaceutical Services Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $98.80 M(+52.5%) | $321.60 M(-9.9%) |
| June 2024 | - | $64.80 M(+134.8%) | $357.10 M(-7.5%) |
| Mar 2024 | - | $27.60 M(-78.8%) | $386.10 M(-6.9%) |
| Dec 2023 | $414.50 M(-5.7%) | $130.40 M(-2.9%) | $414.50 M(-1.3%) |
| Sept 2023 | - | $134.30 M(+43.2%) | $420.00 M(+5.8%) |
| June 2023 | - | $93.80 M(+67.5%) | $396.80 M(-3.2%) |
| Mar 2023 | - | $56.00 M(-58.8%) | $410.00 M(-6.7%) |
| Dec 2022 | $439.40 M(+32.9%) | $135.90 M(+22.3%) | $439.40 M(+13.3%) |
| Sept 2022 | - | $111.10 M(+3.8%) | $387.80 M(-3.4%) |
| June 2022 | - | $107.00 M(+25.3%) | $401.50 M(+5.1%) |
| Mar 2022 | - | $85.40 M(+1.3%) | $382.00 M(+15.5%) |
| Dec 2021 | $330.60 M(+10.9%) | $84.30 M(-32.5%) | $330.60 M(-3.1%) |
| Sept 2021 | - | $124.80 M(+42.6%) | $341.10 M(+18.7%) |
| June 2021 | - | $87.50 M(+157.4%) | $287.40 M(-6.4%) |
| Mar 2021 | - | $34.00 M(-64.1%) | $307.10 M(+3.0%) |
| Dec 2020 | $298.10 M(+23.8%) | $94.80 M(+33.3%) | $298.10 M(+9.6%) |
| Sept 2020 | - | $71.10 M(-33.7%) | $272.10 M(-1.9%) |
| June 2020 | - | $107.20 M(+328.8%) | $277.40 M(+12.3%) |
| Mar 2020 | - | $25.00 M(-63.7%) | $247.00 M(+2.6%) |
| Dec 2019 | $240.80 M(+30.9%) | $68.80 M(-9.9%) | $240.80 M(+11.9%) |
| Sept 2019 | - | $76.40 M(-0.5%) | $215.20 M(+7.2%) |
| June 2019 | - | $76.80 M(+308.5%) | $200.70 M(+8.1%) |
| Mar 2019 | - | $18.80 M(-56.5%) | $185.70 M(+1.0%) |
| Dec 2018 | $183.90 M(+38.8%) | $43.20 M(-30.2%) | $183.90 M(-4.6%) |
| Sept 2018 | - | $61.90 M(+0.2%) | $192.70 M(+11.8%) |
| June 2018 | - | $61.80 M(+263.5%) | $172.30 M(+3.6%) |
| Mar 2018 | - | $17.00 M(-67.3%) | $166.30 M(+25.5%) |
| Dec 2017 | $132.50 M(+169.3%) | $52.00 M(+25.3%) | $132.50 M(+26.4%) |
| Sept 2017 | - | $41.50 M(-25.6%) | $104.80 M(+26.3%) |
| June 2017 | - | $55.80 M(-432.1%) | $83.00 M(+21.3%) |
| Mar 2017 | - | -$16.80 M(-169.1%) | $68.40 M(+39.0%) |
| Dec 2016 | $49.20 M(-39.1%) | $24.30 M(+23.4%) | $49.20 M(+2.3%) |
| Sept 2016 | - | $19.70 M(-52.2%) | $48.10 M(-28.7%) |
| June 2016 | - | $41.20 M(-214.4%) | $67.50 M(-12.5%) |
| Mar 2016 | - | -$36.00 M(-255.2%) | $77.10 M(-4.6%) |
| Dec 2015 | $80.80 M(+14.1%) | $23.20 M(-40.7%) | $80.80 M(+5.9%) |
| Sept 2015 | - | $39.10 M(-23.0%) | $76.30 M(+5.2%) |
| June 2015 | - | $50.80 M(-257.3%) | $72.50 M(+18.1%) |
| Mar 2015 | - | -$32.30 M(-272.7%) | $61.40 M(-13.3%) |
| Dec 2014 | $70.80 M(+9.4%) | $18.70 M(-47.0%) | $70.80 M(-9.5%) |
| Sept 2014 | - | $35.30 M(-11.1%) | $78.20 M(+16.9%) |
| June 2014 | - | $39.70 M(-273.4%) | $66.90 M(-20.9%) |
| Mar 2014 | - | -$22.90 M(-187.7%) | $84.60 M(+30.8%) |
| Dec 2013 | $64.70 M(+16.8%) | $26.10 M(+8.8%) | $64.70 M(-13.5%) |
| Sept 2013 | - | $24.00 M(-58.2%) | $74.80 M(+1.9%) |
| June 2013 | - | $57.40 M(-234.1%) | $73.40 M(+135.3%) |
| Mar 2013 | - | -$42.80 M(-218.2%) | $31.20 M(-43.7%) |
| Dec 2012 | $55.40 M(+63.4%) | $36.20 M(+60.2%) | $55.40 M(+111.5%) |
| Sept 2012 | - | $22.60 M(+48.7%) | $26.20 M(+34.4%) |
| June 2012 | - | $15.20 M(-181.7%) | $19.50 M(-23.8%) |
| Mar 2012 | - | -$18.60 M(-365.7%) | $25.60 M(-24.5%) |
| Dec 2011 | $33.90 M(-47.4%) | $7.00 M(-56.0%) | $33.90 M(-32.3%) |
| Sept 2011 | - | $15.90 M(-25.4%) | $50.10 M(-22.9%) |
| June 2011 | - | $21.30 M(-306.8%) | $65.00 M(+7.6%) |
| Mar 2011 | - | -$10.30 M(-144.4%) | $60.40 M(-6.4%) |
| Dec 2010 | $64.50 M(+115.7%) | $23.20 M(-24.7%) | $64.50 M(-1.2%) |
| Sept 2010 | - | $30.80 M(+84.4%) | $65.30 M(+42.0%) |
| June 2010 | - | $16.70 M(-369.4%) | $46.00 M(-14.3%) |
| Mar 2010 | - | -$6.20 M(-125.8%) | $53.70 M(+79.6%) |
| Dec 2009 | $29.90 M(-829.3%) | $24.00 M(+108.7%) | $29.90 M(-5083.3%) |
| Sept 2009 | - | $11.50 M(-52.9%) | -$600.00 K(-88.0%) |
| June 2009 | - | $24.40 M(-181.3%) | -$5.00 M(+13.6%) |
| Mar 2009 | - | -$30.00 M(+361.5%) | -$4.40 M(+7.3%) |
| Dec 2008 | -$4.10 M(-16.3%) | -$6.50 M(-191.5%) | -$4.10 M(+20.6%) |
| Sept 2008 | - | $7.10 M(-71.6%) | -$3.40 M(-43.3%) |
| June 2008 | - | $25.00 M(-184.2%) | -$6.00 M(-53.1%) |
| Mar 2008 | - | -$29.70 M(+412.1%) | -$12.80 M(+161.2%) |
| Dec 2007 | -$4.90 M | -$5.80 M(-228.9%) | -$4.90 M(-192.5%) |
| Sept 2007 | - | $4.50 M(-75.3%) | $5.30 M(-68.3%) |
| June 2007 | - | $18.20 M(-183.5%) | $16.70 M(-58.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | -$21.80 M(-595.5%) | $40.10 M(-25.0%) |
| Dec 2006 | $53.50 M(+108.2%) | $4.40 M(-72.3%) | $53.50 M(+17.1%) |
| Sept 2006 | - | $15.90 M(-61.8%) | $45.70 M(-9.7%) |
| June 2006 | - | $41.60 M(-595.2%) | $50.60 M(+93.1%) |
| Mar 2006 | - | -$8.40 M(+147.1%) | $26.20 M(+1.9%) |
| Dec 2005 | $25.70 M(+119.7%) | -$3.40 M(-116.3%) | $25.70 M(-30.5%) |
| Sept 2005 | - | $20.80 M(+20.9%) | $37.00 M(+68.2%) |
| June 2005 | - | $17.20 M(-293.3%) | $22.00 M(+134.0%) |
| Mar 2005 | - | -$8.90 M(-212.7%) | $9.40 M(-19.7%) |
| Dec 2004 | $11.70 M(+82.8%) | $7.90 M(+36.2%) | $11.70 M(-320.8%) |
| Sept 2004 | - | $5.80 M(+26.1%) | -$5.30 M(+65.6%) |
| June 2004 | - | $4.60 M(-169.7%) | -$3.20 M(-54.3%) |
| Mar 2004 | - | -$6.60 M(-27.5%) | -$7.00 M(-209.4%) |
| Dec 2003 | $6.40 M(-60.5%) | -$9.10 M(-215.2%) | $6.40 M(-61.2%) |
| Sept 2003 | - | $7.90 M(+887.5%) | $16.50 M(-30.4%) |
| June 2003 | - | $800.00 K(-88.2%) | $23.70 M(-10.9%) |
| Mar 2003 | - | $6.80 M(+580.0%) | $26.60 M(+64.2%) |
| Dec 2002 | $16.20 M(-328.2%) | $1.00 M(-93.4%) | $16.20 M(-27.4%) |
| Sept 2002 | - | $15.10 M(+308.1%) | $22.30 M(+1927.3%) |
| June 2002 | - | $3.70 M(-202.8%) | $1.10 M(-21.4%) |
| Mar 2002 | - | -$3.60 M(-150.7%) | $1.40 M(-119.7%) |
| Dec 2001 | -$7.10 M(-18.4%) | $7.10 M(-216.4%) | -$7.10 M(-57.5%) |
| Sept 2001 | - | -$6.10 M(-252.5%) | -$16.70 M(+46.5%) |
| June 2001 | - | $4.00 M(-133.1%) | -$11.40 M(-33.3%) |
| Mar 2001 | - | -$12.10 M(+384.0%) | -$17.10 M(+96.6%) |
| Dec 2000 | -$8.70 M(-245.0%) | -$2.50 M(+212.5%) | -$8.70 M(-231.8%) |
| Sept 2000 | - | -$800.00 K(-52.9%) | $6.60 M(+15.8%) |
| June 2000 | - | -$1.70 M(-54.1%) | $5.70 M(-267.6%) |
| Mar 2000 | - | -$3.70 M(-128.9%) | -$3.40 M(-156.7%) |
| Dec 1999 | $6.00 M(-205.3%) | $12.80 M(-852.9%) | $6.00 M(-175.9%) |
| Sept 1999 | - | -$1.70 M(-84.3%) | -$7.90 M(+426.7%) |
| June 1999 | - | -$10.80 M(-289.5%) | -$1.50 M(-124.6%) |
| Mar 1999 | - | $5.70 M(-618.2%) | $6.10 M(-207.0%) |
| Dec 1998 | -$5.70 M(-117.1%) | -$1.10 M(-123.4%) | -$5.70 M(+29.5%) |
| Sept 1998 | - | $4.70 M(-246.9%) | -$4.40 M(-210.0%) |
| June 1998 | - | -$3.20 M(-47.5%) | $4.00 M(-82.2%) |
| Mar 1998 | - | -$6.10 M(-3150.0%) | $22.50 M(-32.4%) |
| Dec 1997 | $33.30 M(+5.0%) | $200.00 K(-98.5%) | $33.30 M(-22.0%) |
| Sept 1997 | - | $13.10 M(-14.4%) | $42.70 M(-7.8%) |
| June 1997 | - | $15.30 M(+225.5%) | $46.30 M(+36.2%) |
| Mar 1997 | - | $4.70 M(-51.0%) | $34.00 M(+7.3%) |
| Dec 1996 | $31.70 M(+114.2%) | $9.60 M(-42.5%) | $31.70 M(+10.1%) |
| Sept 1996 | - | $16.70 M(+456.7%) | $28.80 M(+50.0%) |
| June 1996 | - | $3.00 M(+25.0%) | $19.20 M(+12.3%) |
| Mar 1996 | - | $2.40 M(-64.2%) | $17.10 M(+15.5%) |
| Dec 1995 | $14.80 M(-34.8%) | $6.70 M(-5.6%) | $14.80 M(-8.1%) |
| Sept 1995 | - | $7.10 M(+688.9%) | $16.10 M(-8.0%) |
| June 1995 | - | $900.00 K(+800.0%) | $17.50 M(-13.4%) |
| Mar 1995 | - | $100.00 K(-98.8%) | $20.20 M(-11.0%) |
| Dec 1994 | $22.70 M(+354.0%) | $8.00 M(-5.9%) | $22.70 M(-7.0%) |
| Sept 1994 | - | $8.50 M(+136.1%) | $24.40 M(+61.6%) |
| June 1994 | - | $3.60 M(+38.5%) | $15.10 M(+33.6%) |
| Mar 1994 | - | $2.60 M(-73.2%) | $11.30 M(+126.0%) |
| Dec 1993 | $5.00 M(-56.9%) | $9.70 M(-1312.5%) | $5.00 M(-2600.0%) |
| Sept 1993 | - | -$800.00 K(+300.0%) | -$200.00 K(-102.9%) |
| June 1993 | - | -$200.00 K(-94.6%) | $6.80 M(-53.1%) |
| Mar 1993 | - | -$3.70 M(-182.2%) | $14.50 M(+25.0%) |
| Dec 1992 | $11.60 M(-38.6%) | $4.50 M(-27.4%) | $11.60 M(-29.3%) |
| Sept 1992 | - | $6.20 M(-17.3%) | $16.40 M(-9.4%) |
| June 1992 | - | $7.50 M(-213.6%) | $18.10 M(+25.7%) |
| Mar 1992 | - | -$6.60 M(-171.0%) | $14.40 M(-23.8%) |
| Dec 1991 | $18.90 M(+575.0%) | $9.30 M(+17.7%) | $18.90 M(+105.4%) |
| Sept 1991 | - | $7.90 M(+107.9%) | $9.20 M(+114.0%) |
| June 1991 | - | $3.80 M(-281.0%) | $4.30 M(-2250.0%) |
| Mar 1991 | - | -$2.10 M(+425.0%) | -$200.00 K(-107.1%) |
| Dec 1990 | $2.80 M(-67.4%) | -$400.00 K(-113.3%) | $2.80 M(-12.5%) |
| Sept 1990 | - | $3.00 M(-528.6%) | $3.20 M(+1500.0%) |
| June 1990 | - | -$700.00 K(-177.8%) | $200.00 K(-77.8%) |
| Mar 1990 | - | $900.00 K | $900.00 K |
| Dec 1989 | $8.60 M | - | - |
FAQ
- What is West Pharmaceutical Services annual free cash flow?
- What is the all time high annual FCF for West Pharmaceutical Services?
- What is West Pharmaceutical Services annual FCF year-on-year change?
- What is West Pharmaceutical Services quarterly free cash flow?
- What is the all time high quarterly FCF for West Pharmaceutical Services?
- What is West Pharmaceutical Services quarterly FCF year-on-year change?
- What is West Pharmaceutical Services TTM free cash flow?
- What is the all time high TTM FCF for West Pharmaceutical Services?
- What is West Pharmaceutical Services TTM FCF year-on-year change?
What is West Pharmaceutical Services annual free cash flow?
The current annual FCF of WST is $414.50 M
What is the all time high annual FCF for West Pharmaceutical Services?
West Pharmaceutical Services all-time high annual free cash flow is $439.40 M
What is West Pharmaceutical Services annual FCF year-on-year change?
Over the past year, WST annual free cash flow has changed by -$24.90 M (-5.67%)
What is West Pharmaceutical Services quarterly free cash flow?
The current quarterly FCF of WST is $98.80 M
What is the all time high quarterly FCF for West Pharmaceutical Services?
West Pharmaceutical Services all-time high quarterly free cash flow is $135.90 M
What is West Pharmaceutical Services quarterly FCF year-on-year change?
Over the past year, WST quarterly free cash flow has changed by -$35.50 M (-26.43%)
What is West Pharmaceutical Services TTM free cash flow?
The current TTM FCF of WST is $321.60 M
What is the all time high TTM FCF for West Pharmaceutical Services?
West Pharmaceutical Services all-time high TTM free cash flow is $439.40 M
What is West Pharmaceutical Services TTM FCF year-on-year change?
Over the past year, WST TTM free cash flow has changed by -$98.40 M (-23.43%)